Deciphera Pharmaceuticals (DCPH) Earnings Date, Estimates & Call Transcripts → Move Your Money Before May 22 (From Stansberry Research) (Ad) Free DCPH Stock Alerts $14.66 +0.48 (+3.39%) (As of 02:50 PM ET) Add Compare Share Share EarningsStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaSustainabilityStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaSustainability Earnings SummaryUpcoming Earnings DateMay. 1EstimatedActual EPS (Feb. 6) -$0.54 Beat By $0.04 Consensus EPS (Feb. 6) -$0.58 Read Call TranscriptListen to CallLatest SEC 10-Q Filing Get Deciphera Pharmaceuticals Earnings AlertsEnter your email address below to receive the latest news and earnings results for DCPH and its competitors with MarketBeat's FREE daily newsletter. Skip Charts & View Estimated and Actual Earnings DataEarnings Per ShareRevenueDCPH Earnings Estimates and Actuals by QuarterEarnings Estimates and Acutals by Quarter Chart DescriptionThe chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.DCPH Estimated and Actual Revenue by Quarter Estimated Revenue and Actual Revenue by Quarter Chart DescriptionThe chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter. Ad Stansberry ResearchMove Your Money Before May 1Did you know that the IRS has allegedly been using AI to spy on the bank accounts of American citizens? Click here to get the full story before May 1. Deciphera Pharmaceuticals Analyst EPS EstimatesQuarterNumber of EstimatesLow EstimateHigh EstimateAverage EstimateCompany GuidanceQ1 20243($0.63)($0.50)($0.59) Q2 20243($0.66)($0.49)($0.59) Q3 20243($0.65)($0.48)($0.58) Q4 20243($0.64)($0.48)($0.56) FY 202412($2.58)($1.95)($2.32) Q1 20251($0.55)($0.55)($0.55) Q2 20251($0.53)($0.53)($0.53) Q3 20251($0.47)($0.47)($0.47) Q4 20251($0.40)($0.40)($0.40) FY 20254($1.95)($1.95) ($1.95)DCPH Earnings Date and InformationDeciphera Pharmaceuticals last released its earnings data on February 6th, 2024. The reported ($0.54) earnings per share (EPS) for the quarter, topping the consensus estimate of ($0.58) by $0.04. The business had revenue of $48.30 million for the quarter, compared to analyst estimates of $45.93 million. Its revenue for the quarter was up 32.9% on a year-over-year basis. Deciphera Pharmaceuticals has generated ($2.29) earnings per share over the last year (($2.29) diluted earnings per share). Earnings for Deciphera Pharmaceuticals are expected to grow in the coming year, from ($2.16) to ($1.74) per share. Deciphera Pharmaceuticals has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Wednesday, May 1st, 2024 based off prior year's report dates.Read More Deciphera Pharmaceuticals Earnings History by Quarter Custom Range 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years 5 Years Time Frame * Start Date * End Date Export to Excel DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueCall Transcript 5/1/2024Estimated)------- 2/6/2024Q4 2023($0.58)($0.54)+$0.04($0.54)$45.93 million$48.30 million 10/30/2023Q3 2023($0.61)($0.58)+$0.03($0.58)$39.66 million$43.31 million 8/9/2023Q2 2023($0.62)($0.57)+$0.05($0.57)$36.09 million$38.30 million 5/3/2023Q1 2023($0.60)($0.60)-($0.60)$35.50 million$33.45 million 2/7/2023Q4 2022($0.57)($0.60)($0.03)($0.60)$35.88 million$36.40 million 11/3/2022Q3 2022($0.57)($0.55)+$0.02($0.55)$33.29 million$35.97 million Get the Latest News and Ratings for DCPH and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Deciphera Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. 8/4/2022Q2 2022($0.65)($0.60)+$0.05($0.60)$30.11 million$32.49 million 5/4/2022Q1 2022($0.84)($0.80)+$0.04($0.80)$27.17 million$29.22 million 2/8/2022Q4 2021($1.49)($1.51)($0.02)($1.51)$23.28 million$24.20 million 11/2/2021Q3 2021($1.29)($1.37)($0.08)($1.37)$23.73 million$23.22 million 8/3/2021Q2 2021($1.15)($1.21)($0.06)($1.21)$22.25 million$23.57 million 5/4/2021Q1 2021($1.08)($1.06)+$0.02($1.06)$21.35 million$25.16 million Deciphera Pharmaceuticals Earnings - Frequently Asked Questions When is Deciphera Pharmaceuticals's earnings date? Deciphera Pharmaceuticals has not confirmed its next earnings publication date, but the company's estimated earnings date is Wednesday, May 1st, 2024 based off last year's report dates. Learn more on DCPH's earnings history. Did Deciphera Pharmaceuticals beat their earnings estimates last quarter? In the previous quarter, Deciphera Pharmaceuticals (NASDAQ:DCPH) reported ($0.54) earnings per share (EPS) to beat the analysts' consensus estimate of ($0.58) by $0.04. Learn more on analysts' earnings estimate vs. DCPH's actual earnings. How can I listen to Deciphera Pharmaceuticals's earnings conference call? The conference call for Deciphera Pharmaceuticals's latest earnings report can be listened to online. Listen to Conference Call How can I read Deciphera Pharmaceuticals's conference call transcript? The conference call transcript for Deciphera Pharmaceuticals's latest earnings report can be read online. Read Transcript How can I view Deciphera Pharmaceuticals's earnings report? Deciphera Pharmaceuticals's earnings report can be found in their filing with the SEC. View SEC filing How much revenue does Deciphera Pharmaceuticals generate each year? Deciphera Pharmaceuticals (NASDAQ:DCPH) has a recorded annual revenue of $163.36 million. How much profit does Deciphera Pharmaceuticals generate each year? Deciphera Pharmaceuticals (NASDAQ:DCPH) has a recorded net income of -$194.94 million. DCPH has generated -$2.29 earnings per share over the last four quarters. What is Deciphera Pharmaceuticals's EPS forecast for next year? Deciphera Pharmaceuticals's earnings are expected to grow from ($2.16) per share to ($1.74) per share in the next year. More Earnings Resources from MarketBeat Related Companies: AbCellera Biologics Earnings Kiniksa Pharmaceuticals Earnings Ironwood Pharmaceuticals Earnings Collegium Pharmaceutical Earnings Ocular Therapeutix Earnings Xencor Earnings Pacira BioSciences Earnings Prothena Earnings Mirum Pharmaceuticals Earnings Day One Biopharmaceuticals Earnings Earnings Tools: Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Earnings By Country: U.S. Earnings Reports Canadian Earnings Reports U.K. Earnings Reports Australia Earnings Reports Latest Articles: GE Aerospace is Ready for Liftoff After Strong EarningsTaiwan Semiconductor Earnings: AI Dominance and Future OutlookCSX Co.: The Railroad Powering Ahead with an Earnings Beat What's Driving Tesla Lower Ahead of its Earnings?Blackrock vs. State Street: Earnings in a Volatile MarketWhat to Expect From the Q1 Earnings Reporting SeasonLululemon Stock Implodes Post Earnings, Guidance Muted This page (NASDAQ:DCPH) was last updated on 4/26/2024 by MarketBeat.com Staff From Our PartnersThese AI trades triggered this morning (545% return)Prosper Trading AcademyThe Best AI Stock to Own in the World Today is Trading for Just $25Banyan Hill PublishingConflict In Israel Sends Gold Soaring ???? Here’s How To Get Your ShareColonial MetalsThe A.I. story nobody is telling you (Read ASAP)TradeSmithDid You Get Your Free Bitcoin Yet?Crypto Swap ProfitsFed launches fourth dollar overhaulStansberry ResearchMan Who Predicted 2008: “This Will be Worse.”AltimetryJim Cramer’s “The Biggest Drug Ever”Behind the Markets Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Deciphera Pharmaceuticals, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
